207 related articles for article (PubMed ID: 27918020)
1. Effects of ovalbumin protein nanoparticle vaccine size and coating on dendritic cell processing.
Chang TZ; Stadmiller SS; Staskevicius E; Champion JA
Biomater Sci; 2017 Jan; 5(2):223-233. PubMed ID: 27918020
[TBL] [Abstract][Full Text] [Related]
2. Polymer nanoparticles for enhanced immune response: combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells.
Heo MB; Cho MY; Lim YT
Acta Biomater; 2014 May; 10(5):2169-76. PubMed ID: 24394635
[TBL] [Abstract][Full Text] [Related]
3. Effects of gold nanoparticle-based vaccine size on lymph node delivery and cytotoxic T-lymphocyte responses.
Kang S; Ahn S; Lee J; Kim JY; Choi M; Gujrati V; Kim H; Kim J; Shin EC; Jon S
J Control Release; 2017 Jun; 256():56-67. PubMed ID: 28428066
[TBL] [Abstract][Full Text] [Related]
4. Lignin nanoparticles as a promising vaccine adjuvant and delivery system for ovalbumin.
Alqahtani MS; Kazi M; Ahmad MZ; Syed R; Alsenaidy MA; Albraiki SA
Int J Biol Macromol; 2020 Nov; 163():1314-1322. PubMed ID: 32645499
[TBL] [Abstract][Full Text] [Related]
5. A visible fluorescent nanovaccine based on functional genipin crosslinked ovalbumin protein nanoparticles.
Dong X; Sun Z; Liang J; Wang H; Zhu D; Leng X; Wang C; Kong D; Lv F
Nanomedicine; 2018 Jun; 14(4):1087-1098. PubMed ID: 29474923
[TBL] [Abstract][Full Text] [Related]
6. Neutral polymer micelle carriers with pH-responsive, endosome-releasing activity modulate antigen trafficking to enhance CD8(+) T cell responses.
Keller S; Wilson JT; Patilea GI; Kern HB; Convertine AJ; Stayton PS
J Control Release; 2014 Oct; 191():24-33. PubMed ID: 24698946
[TBL] [Abstract][Full Text] [Related]
7. Rational Design of PLGA Nanoparticle Vaccine Delivery Systems To Improve Immune Responses.
Gu P; Wusiman A; Zhang Y; Liu Z; Bo R; Hu Y; Liu J; Wang D
Mol Pharm; 2019 Dec; 16(12):5000-5012. PubMed ID: 31621331
[TBL] [Abstract][Full Text] [Related]
8. Intracellular signaling pathway in dendritic cells and antigen transport pathway in vivo mediated by an OVA@DDAB/PLGA nano-vaccine.
Han S; Ma W; Jiang D; Sutherlin L; Zhang J; Lu Y; Huo N; Chen Z; Engle JW; Wang Y; Xu X; Kang L; Cai W; Wang L
J Nanobiotechnology; 2021 Nov; 19(1):394. PubMed ID: 34838057
[TBL] [Abstract][Full Text] [Related]
9. Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigen.
Slütter B; Soema PC; Ding Z; Verheul R; Hennink W; Jiskoot W
J Control Release; 2010 Apr; 143(2):207-14. PubMed ID: 20074597
[TBL] [Abstract][Full Text] [Related]
10. Enhanced stimulation of anti-breast cancer T cells responses by dendritic cells loaded with poly lactic-co-glycolic acid (PLGA) nanoparticle encapsulated tumor antigens.
Iranpour S; Nejati V; Delirezh N; Biparva P; Shirian S
J Exp Clin Cancer Res; 2016 Oct; 35(1):168. PubMed ID: 27782834
[TBL] [Abstract][Full Text] [Related]
11. Dendrimer-like alpha-d-glucan nanoparticles activate dendritic cells and are effective vaccine adjuvants.
Lu F; Mencia A; Bi L; Taylor A; Yao Y; HogenEsch H
J Control Release; 2015 Apr; 204():51-9. PubMed ID: 25747143
[TBL] [Abstract][Full Text] [Related]
12. Targeted antigen delivery to dendritic cell via functionalized alginate nanoparticles for cancer immunotherapy.
Zhang C; Shi G; Zhang J; Song H; Niu J; Shi S; Huang P; Wang Y; Wang W; Li C; Kong D
J Control Release; 2017 Jun; 256():170-181. PubMed ID: 28414151
[TBL] [Abstract][Full Text] [Related]
13. Activation of dendritic cells and induction of CD4(+) T cell differentiation by aluminum-containing adjuvants.
Sokolovska A; Hem SL; HogenEsch H
Vaccine; 2007 Jun; 25(23):4575-85. PubMed ID: 17485153
[TBL] [Abstract][Full Text] [Related]
14. Ferritin protein cage nanoparticles as versatile antigen delivery nanoplatforms for dendritic cell (DC)-based vaccine development.
Han JA; Kang YJ; Shin C; Ra JS; Shin HH; Hong SY; Do Y; Kang S
Nanomedicine; 2014 Apr; 10(3):561-9. PubMed ID: 24262997
[TBL] [Abstract][Full Text] [Related]
15. Nanogel vaccines targeting dendritic cells: contributions of the surface decoration and vaccine cargo on cell targeting and activation.
Thomann-Harwood LJ; Kaeuper P; Rossi N; Milona P; Herrmann B; McCullough KC
J Control Release; 2013 Mar; 166(2):95-105. PubMed ID: 23220107
[TBL] [Abstract][Full Text] [Related]
16. pH-Responsive Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response.
Liu Q; Chen X; Jia J; Zhang W; Yang T; Wang L; Ma G
ACS Nano; 2015 May; 9(5):4925-38. PubMed ID: 25898266
[TBL] [Abstract][Full Text] [Related]
17. Improved vaccine-induced immune responses via a ROS-triggered nanoparticle-based antigen delivery system.
Liang X; Duan J; Li X; Zhu X; Chen Y; Wang X; Sun H; Kong D; Li C; Yang J
Nanoscale; 2018 May; 10(20):9489-9503. PubMed ID: 29675543
[TBL] [Abstract][Full Text] [Related]
18. Protein-bound polysaccharide activates dendritic cells and enhances OVA-specific T cell response as vaccine adjuvant.
Engel AL; Sun GC; Gad E; Rastetter LR; Strobe K; Yang Y; Dang Y; Disis ML; Lu H
Immunobiology; 2013 Dec; 218(12):1468-76. PubMed ID: 23735481
[TBL] [Abstract][Full Text] [Related]
19. Size-dependent accumulation of particles in lysosomes modulates dendritic cell function through impaired antigen degradation.
Seydoux E; Rothen-Rutishauser B; Nita IM; Balog S; Gazdhar A; Stumbles PA; Petri-Fink A; Blank F; von Garnier C
Int J Nanomedicine; 2014; 9():3885-902. PubMed ID: 25152619
[TBL] [Abstract][Full Text] [Related]
20. The crystal structure of titanium dioxide nanoparticles influences immune activity in vitro and in vivo.
Vandebriel RJ; Vermeulen JP; van Engelen LB; de Jong B; Verhagen LM; de la Fonteyne-Blankestijn LJ; Hoonakker ME; de Jong WH
Part Fibre Toxicol; 2018 Jan; 15(1):9. PubMed ID: 29382351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
